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Osteoporosis is currently considered a skeletal disease
characterized by a diminished resistance of bone tissue,
which predisposes to a greater risk of fractures. This dis-
ease, which affects mainly postmenopausal women, is
constantly increasing, especially owing to a longer life-
span; reliable epidemiological studies have reported that
all over the world there are more than 200 million osteo-
porotic subjects. Osteoporosis is evaluated by calculating
bone mineral density (BMD), analyzing bone quality, and
estimating risk factors. BMD is calculated using DEXA
(Dual-Energy Xray Absorptiometry), QCT (Quantitative
Computed Tomography), and QUS (Quantitative Ultra-
sonography). The analysis of bone quality includes var-
ious factors such as microarchitecture, geometry, bone
turnover, mineralization, and the properties of collagen
and the extracellular matrix. The most common risk fac-
tors for osteoporosis are hereditary predisposition, sex,
age, early menopause, smoking, use of corticosteroid
drugs for long periods of time, malabsorption, and endo-
crine disorders. The orthopedic surgeon is increasingly
more involved in treating so-called fragility fractures
caused by osteoporosis. The sites most frequently
affected by these fractures are the femoral neck, the prox-
imal part of the humerus, the vertebrae, and the distal
part of the radius. Currently, fragility fractures are often
treated surgically by using devices, which allow obtaining
stable internal fixation in a less resistant bone and early
joint mobilization. In fact, the study of the most recent
surgical devices has been oriented toward finding materi-
als with osteoconductive and osteoinductive properties,
which can be used while respecting and supporting the
bone’s regenerative capacity. As far as medical treatment
of osteoporosis is concerned, the most widely used drugs
are bisphosphonates, peptides of the parathyroid hor-
mone, selective modulators of estrogen receptors, and
strontium ranelate. At present, the researchers involved
in this problem are studying new drugs which not only
treat the disease but can also be used to support the heal-
ing process of fractures in osteoporotic patients including
those treated surgically, thereby enhancing the bone tis-
sue’s regenerative potential and improving its mechanical
properties.
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